scholarly article | Q13442814 |
P356 | DOI | 10.1136/ANNRHEUMDIS-2013-205127 |
P8608 | Fatcat ID | release_55o2bvxq7nd7ndop2h7kzwzuhe |
P698 | PubMed publication ID | 24695011 |
P50 | author | Øyvind Molberg | Q42170795 |
Lars Grøvle | Q114093196 | ||
P2093 | author name string | Jan Tore Gran | |
Torhild Garen | |||
Cecilie Dobloug | |||
Johan Stjärne | |||
Guri Stenseth | |||
Helle Bitter | |||
Marthe Sem | |||
P2860 | cites work | Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study | Q28200349 |
Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences | Q31172576 | ||
Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota | Q33917581 | ||
Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis | Q34306432 | ||
Polymyositis and dermatomyositis | Q34542218 | ||
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype | Q34896166 | ||
Autoantibody profiles in the sera of European patients with myositis | Q35550062 | ||
Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy | Q35638565 | ||
Diagnosis and treatment of the idiopathic inflammatory myopathies | Q36059440 | ||
Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. | Q36947409 | ||
Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features | Q37764006 | ||
Neurologists are from Mars. Rheumatologists are from Venus: differences in approach to classifying the idiopathic inflammatory myopathies | Q37788945 | ||
Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis | Q44810312 | ||
Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan | Q46107385 | ||
Occurrence of polymyositis in the county of Gävleborg, Sweden | Q50621751 | ||
Polymyositis-dermatomyositis: incidence in Spain (1997-2004) | Q51110758 | ||
Polymyositis: a survey of 89 cases with particular reference to treatment and prognosis | Q51225592 | ||
119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands | Q57752724 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dermatomyositis | Q681160 |
polymyositis | Q980926 | ||
P304 | page(s) | 1551-1556 | |
P577 | publication date | 2014-04-02 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | Prevalence and clinical characteristics of adult polymyositis and dermatomyositis; data from a large and unselected Norwegian cohort | |
P478 | volume | 74 |
Q64094676 | Clinical characteristics and outcome in patients with antisynthetase syndrome associated interstitial lung disease: a retrospective cohort study |
Q36842501 | Clinical characteristics of patients with anti-TIF1-γ antibodies |
Q37604939 | Comparative analyses of muscle MRI and muscular function in anti-synthetase syndrome patients and matched controls: a cross-sectional study |
Q64054802 | Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases |
Q38296485 | High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study |
Q38355216 | Idiopathic inflammatory myopathies-a review |
Q26861123 | Imaging: seeing muscle in new ways |
Q52628910 | Immune-Mediated Necrotizing Myopathy. |
Q100946511 | Immune-mediated necrotizing myopathy: clinical features and pathogenesis |
Q64231412 | Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study |
Q38761660 | Incidence and prevalence of idiopathic inflammatory myopathies in Sweden: a nationwide population-based study |
Q38813077 | Increased Incidence of Amyotrophic Lateral Sclerosis in Polymyositis: A Nationwide Cohort Study |
Q92737241 | Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: a 10-year epidemiological study |
Q39027323 | Integrated classification of inflammatory myopathies |
Q90156828 | Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients |
Q89876451 | Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort |
Q38589395 | Role of MRI in diagnosis and management of idiopathic inflammatory myopathies |
Q38654184 | TEST performance of a myositis panel in a clinical immunology laboratory in New South Wales, Australia |
Q38700961 | The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review |
Q49910154 | The clinical phenotype of patients positive for antibodies to myositis and myositis-related disorders |
Q64998657 | The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort. |
Q90647761 | The spectrum of idiopathic inflammatory myopathies in South Africa |
Q42292003 | Toll-Like Receptor 4-Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model |
Q59808437 | Traditional Korean Medicine Treatment for Patients with Wilting Disorder: A Literature Review of In Vivo Studies |
Q54979971 | Treatment of adult idiopathic inflammatory myopathies with conventional immunosuppressive drugs : Results of a retrospective study. |
Q58099249 | Whole-body MRI and pathological findings in adult patients with myopathies |
Search more.